...
首页> 外文期刊>Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research >Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5.
【24h】

Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5.

机译:由于Lrp5突变而导致高骨质量表型患者的血清素,硬化素,骨转换标志物水平以及骨密度和微结构水平。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Patients with an activation mutation of the Lrp5 gene exhibit high bone mass (HBM). Limited information is available regarding compartment-specific changes in bone. The relationship between the phenotype and serum serotonin is not well documented. To evaluate bone, serotonin, and bone turnover markers (BTM) in Lrp5-HBM patients, we studied 19 Lrp5-HBM patients (T253I) and 19 age- and sex-matched controls. DXA and HR-pQCT were used to assess BMD and bone structure. Serum serotonin, sclerostin, dickkopf-related protein 1 (DKK1), and BTM were evaluated. Z-scores for the forearm, total hip, lumbar spine, forearm, and whole body were significantly increased (mean +/- SD) between 4.94 +/- 1.45 and 7.52 +/- 1.99 in cases versus -0.19 +/- 1.19 to 0.58 +/- 0.84 in controls. Tibial and radial cortical areas, thicknesses, and BMD were significantly higher in cases. In cases, BMD at the lumbar spine and forearm and cortical thickness were positively associated and trabecular area negatively associated with age (r = 0.49, 0.57, 0.74, and -0.61, respectively, p < .05). Serotonin was lowest in cases (69.5 [29.9-110.4] ng/mL versus 119.4 [62.3-231.0] ng/mL, p < .001) and inversely associated with tibial cortical density (r = -0.49, p < .05) and directly with osteocalcin (OC), bone-specific alkaline phosphatase (B-ALP), and procollagen type 1 amino-terminal propeptide (PINP) (r = 0.52-0.65, p < .05) in controls only. OC and S-CTX were lower and sclerostin higher in cases, whereas B-ALP, PINP, tartrate-resistant acid phosphatase (TRAP), and dickkopf-related protein 1 (DKK1) were similar in cases and controls. In conclusion, increased bone mass in Lrp5-HBM patients seems to be caused primarily by changes in trabecular and cortical bone mass and structure. The phenotype appeared to progress with age, but BTM did not suggest increased bone formation. (c) 2011 American Society for Bone and Mineral Research.
机译:具有Lrp5基因激活突变的患者表现出高骨量(HBM)。关于骨的特定于隔室的变化的信息有限。表型与血清5-羟色胺之间的关系尚未得到充分证明。为了评估Lrp5-HBM患者的骨,血清素和骨转换标记(BTM),我们研究了19名Lrp5-HBM患者(T253I)和19个年龄和性别匹配的对照。 DXA和HR-pQCT用于评估BMD和骨骼结构。评估血清5-羟色胺,硬化素,dickkopf相关蛋白1(DKK1)和BTM。患者的前臂,全髋,腰椎,前臂和全身的Z值在4.94 +/- 1.45和7.52 +/- 1.99之间显着增加(平均值+/- SD),而-0.19 +/- 1.19对照中为0.58 +/- 0.84。病例的胫骨和radial骨皮质区域,厚度和BMD明显较高。在某些情况下,腰椎和前臂的BMD和皮质厚度与年龄呈正相关,而小梁区域与年龄呈负相关(r分别为0.49、0.57、0.74和-0.61,p <.05)。血清素最低(69.5 [29.9-110.4] ng / mL,而119.4 [62.3-231.0] ng / mL,p <.001)与胫骨皮质密度呈反比关系(r = -0.49,p <.05)和仅在对照中直接与骨钙素(OC),骨特异性碱性磷酸酶(B-ALP)和1型胶原原氨基末端肽(PINP)结合使用(r = 0.52-0.65,p <.05)。在病例和对照中,OC和S-CTX较低,而硬化蛋白较高,而B-ALP,PINP,抗酒石酸酸性磷酸酶(TRAP)和与dickkopf相关的蛋白1(DKK1)相似。总之,Lrp5-HBM患者的骨量增加似乎主要是由小梁和皮质骨量和结构的变化引起的。该表型似乎随着年龄的增长而发展,但BTM并未提示骨形成增加。 (c)2011年美国骨矿物质研究学会。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号